2003
DOI: 10.1007/s00424-003-1025-z
|View full text |Cite
|
Sign up to set email alerts
|

Regulation of K-Cl cotransport by Syk and Src protein tyrosine kinases in deoxygenated sickle cells

Abstract: Protein tyrosine kinases (PTK) of the Src family are thought to suppress K-Cl cotransport (KCC) activity via negative regulation of protein phosphatases. However, some PTK inhibitors reduce KCC activity, suggesting opposite regulation by different PTK families. We have reported previously that deoxygenation of sickle cells stimulates KCC and activates Syk (a Syk family PTK), but not Lyn (an Src family PTK). In this study the same results were obtained when PTK activities were measured under the conditions used… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
14
0

Year Published

2004
2004
2019
2019

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(14 citation statements)
references
References 43 publications
0
14
0
Order By: Relevance
“…26,28,29 Tyrosine phosphorylation modulates the system in complex ways, with some tyrosine kinase inhibitors activating KCC 33 and others inhibiting. 34,35 Some of these effects may be mediated by modulation of protein phosphatase activity by tyrosine phosphorylation 36 and may explain the complex kinetics that have prompted more complicated models of KCC activation. 1,37 Nevertheless, a 2-stage model involving activation by protein phosphatase(s) and inactivation by a volume-sensitive kinase explains most of the kinetics of KCC activation (for more detail, see Document S1, available on the Blood website; see the Supplemental Materials link at the top of the online article).…”
Section: Discussionmentioning
confidence: 99%
“…26,28,29 Tyrosine phosphorylation modulates the system in complex ways, with some tyrosine kinase inhibitors activating KCC 33 and others inhibiting. 34,35 Some of these effects may be mediated by modulation of protein phosphatase activity by tyrosine phosphorylation 36 and may explain the complex kinetics that have prompted more complicated models of KCC activation. 1,37 Nevertheless, a 2-stage model involving activation by protein phosphatase(s) and inactivation by a volume-sensitive kinase explains most of the kinetics of KCC activation (for more detail, see Document S1, available on the Blood website; see the Supplemental Materials link at the top of the online article).…”
Section: Discussionmentioning
confidence: 99%
“…S4). Because many of these transporters are also regulated by tyrosine phosphorylation (49,50), and because their malfunction can contribute to human disease, it will be important in the future to determine whether their structures contain a functional SH2-like motif similar to that discovered here and whether their mechanism of regulation resembles that depicted in Fig. 4E.…”
Section: Discussionmentioning
confidence: 99%
“…With the evidence for a functional SH2-like motif in the membrane-spanning domain of band 3 now established, and with considerable data showing that many other membrane-spanning solute transporters are also regulated by tyrosine kinases (49,50), the question naturally arose of whether other membrane-spanning proteins might have evolved a similar functional SH2 signature sequence to enable their regulation by tyrosine kinases. Examination of the literature reveals that sequences similar to GSFLVR can indeed be found in numerous transport proteins, ranging from neurotransmitter symporters to glucose transporters to cation-Cl − electroneutral cotransporters, etc.…”
Section: Discussionmentioning
confidence: 99%
“…Activation involves dephosphorylation of a serine (threonine) residue, probably by protein phosphatase 1 (PP1) 9,10 or PP2A. 11 There is also evidence for control by tyrosine phosphorylation; in fact, certain tyrosine kinase inhibitors activate KCC, 12,13 whereas others inhibit, 14,15 suggesting multiple control points, including PP1 itself. 16,17 Activation by cell swelling appears to involve inhibition of a putative volume-sensitive serine/threonine kinase, which maintains the system in a phosphorylated, quiescent state.…”
Section: Introductionmentioning
confidence: 99%